神经因子MANF介导的单核/巨噬细胞表型及功能的可塑性对肝纤维化的抑制作用及机制研究
批准号:
81973336
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
沈玉先
依托单位:
学科分类:
抗炎与免疫药物药理
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
沈玉先
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
肝巨噬细胞(Mø)在肝纤维化中有双重作用,但关键调控分子不清。我们发现MANF在纤维化肝脏高表达,重组人MANF抑制鼠肝纤维化,增加M2型Mø数;单核/Mø特异性MANF敲除(MKO)增加肝脏M1型Mø数和促炎因子水平;重组人MANF进入Mø受TLR4调节。推测肝脏炎症上调Mø表达和分泌MANF,通过调节Mø的TLR4/NF-B信号通路改变Mø表型和功能,抑制肝星状细胞(HSC)活化和肝纤维化。拟研究内容:1.观察人肝炎和鼠纤维化肝组织MANF表达与Mø异质性、肝纤维化关系;2.观察MANF敲低或过表达或给予重组人MANF对Mø表型和功能的影响;3.采用MKO鼠研究MANF缺失对Mø异质性、HSC活化及肝纤维化影响;4.阐明MANF通过TLR4/NF-B信号通路抑制肝纤维化机制。该研究将阐释MANF调控Mø可塑性抑制肝纤维化的新机制,也为将MANF作为药物靶点或靶点药物的临床实践奠定基础。
英文摘要
Hepatic macrophages have been proved to play a dual role of pro-inflammation and anti-inflammation in the progression of liver fibrosis due to their heterogeneity, but there are still insufficient evidences to demonstrate the key factors that involved in the heterogeneity modulation. Our previous studies have showed that mesencephalicastrocyte-derived neurotrophic factor (MANF) was up-regulated in macrophages in the fibrosic liver tissues. Recombinant human MANF inhibited CCl4-induced mice liver fibrosis and increased the number of M2 macrophages. On the contrary, mono-macrophage-specific MANF knockout increased the number of M1 macrophages and the production of pro-inflammatory factors. Therefore, we hypothesized that chronic inflammation promotes the high expression of MANF in Kupffer cells and monocyte-derived hepatic macrophages that promotes transformation of macrophages subpopulation and initiates hepatic stellate cells activation and liver fibrosis via regulation of TLR4/NF-B signal pathway. To address this hypothesis, we will do as follows: (1) We will examine MANF expression in human hepatic tissues with hepatitis B infection and mouse hepatic tissues with CCl4-induce hepatic fibrosis. Meanwhile, the correlation between MANF expression and hepatic macrophages phenotypes and function and hepatic fibrosis degree will be analyzed; (2) We will use the stable cell lines in that MANF was knocked down or over-expressed or use the cells treated with recombinant human MANF to study the regulation of MANF in hepatic macrophages subpopulation and function under environmental stimuli (inflammation, ER stress, etc); (3) We have established the monocyte/macrophage-specific MANF knock-out mice. The impact of MANF on hepatic macrophages subpopulation/function and hepatic fibrosis will be explored by using the mice model. (4) We will further explore the underlying mechanisms by which MANF regulates macrophages differentiation and hepatic stellate cells function via TLR4/NF-kappa B signal pathway. This study may uncover a novel mechanism that MANF contributes to the heterogeneity of hepatic macrophages, which may be helpful for understanding the pathogenesis of hepatic fibrosis and the function of MANF in tissue-specific immunoregulation and shed a light on the further study on developing new therapeutic agents for chronic liver injury.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1111/liv.14697
发表时间:2020-10
期刊:Liver International
影响因子:6.7
作者:Yi Yang;Peng Wang;Chaoyi Zhang;Fan Huang;Gao-zong Pang;Chuan-sheng Wei;Changming Lv;Goma Chhetri;Tongcui Jiang;Jun Liu;Yujun Shen;Yuxian Shen
通讯作者:Yi Yang;Peng Wang;Chaoyi Zhang;Fan Huang;Gao-zong Pang;Chuan-sheng Wei;Changming Lv;Goma Chhetri;Tongcui Jiang;Jun Liu;Yujun Shen;Yuxian Shen
DOI:10.1038/s41401-022-00920-8
发表时间:2022-06
期刊:Acta Pharmacologica Sinica
影响因子:8.2
作者:Han-yang Xu;Yan-Hong Jiao;Shi-yu Li;Xu-Hong Zhu;Sheng Wang;Yu-Yang Zhang;Yi-jun Wei;Yu-jun Shen;Wei Wang;Yu-xian Shen;Jun-Tang Shao
通讯作者:Han-yang Xu;Yan-Hong Jiao;Shi-yu Li;Xu-Hong Zhu;Sheng Wang;Yu-Yang Zhang;Yi-jun Wei;Yu-jun Shen;Wei Wang;Yu-xian Shen;Jun-Tang Shao
DOI:10.1155/2020/9034864
发表时间:2020-07-07
期刊:OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
影响因子:--
作者:Chhetri, Goma;Liang, Yanyan;Shen, Yuxian
通讯作者:Shen, Yuxian
Mesencephalic astrocyte-derived neurotrophic factor reprograms macrophages to ameliorate acetaminophen-induced acute liver injury via p38 MAPK pathway.
中脑星形胶质细胞源性神经营养因子通过 p38 MAPK 通路重编程巨噬细胞以改善对乙酰氨基酚诱导的急性肝损伤
DOI:10.1038/s41419-022-04555-9
发表时间:2022-02-02
期刊:Cell death & disease
影响因子:9
作者:Hou X;Liu Q;Gao Y;Yong L;Xie H;Li W;Zhou Y;Liu J;Feng L;Xu L;Shen Y;Wang H
通讯作者:Wang H
DOI:10.1038/s41401-022-01045-8
发表时间:2023-06
期刊:ACTA PHARMACOLOGICA SINICA
影响因子:8.2
作者:Yang, Lin;Shen, Wen-wen;Shao, Wei;Zhao, Qing;Pang, Gao-zong;Yang, Yi;Tao, Xiao-fang;Zhang, Wei-ping;Mei, Qiong;Shen, Yu-xian
通讯作者:Shen, Yu-xian
内质网应激蛋白MANF通过与过氧化还原酶6相互作用调节肝细胞的谱系定型及恶性转化研究
- 批准号:U21A20345
- 项目类别:--
- 资助金额:264万元
- 批准年份:2021
- 负责人:沈玉先
- 依托单位:
肝细胞源性神经营养因子MANF经外泌体靶向HSCs的抗肝纤维化作用及机制研究
- 批准号:81673438
- 项目类别:面上项目
- 资助金额:60.0万元
- 批准年份:2016
- 负责人:沈玉先
- 依托单位:
新型神经营养因子MANF对肝细胞癌的抑制作用及其机制研究
- 批准号:81372576
- 项目类别:面上项目
- 资助金额:85.0万元
- 批准年份:2013
- 负责人:沈玉先
- 依托单位:
炎症诱导的ARMET转录激活及其对NF-κB信号通路的调节机制
- 批准号:81173074
- 项目类别:面上项目
- 资助金额:63.0万元
- 批准年份:2011
- 负责人:沈玉先
- 依托单位:
内质网应激在乙型肝炎-肝硬化-肝癌转化过程中的调节机制及相关药物作用靶分子筛选
- 批准号:91129729
- 项目类别:重大研究计划
- 资助金额:80.0万元
- 批准年份:2011
- 负责人:沈玉先
- 依托单位:
内质网应激蛋白ARMET对关节炎滑膜细胞过度增殖的负性调节作用
- 批准号:81072651
- 项目类别:面上项目
- 资助金额:10.0万元
- 批准年份:2010
- 负责人:沈玉先
- 依托单位:
泛素连接酶Hrd1介导的tau蛋白降解
- 批准号:30772557
- 项目类别:面上项目
- 资助金额:34.0万元
- 批准年份:2007
- 负责人:沈玉先
- 依托单位:
泛素连接酶hHrd1对α1-抗胰蛋白酶Z变异型降解的调控机制
- 批准号:30572219
- 项目类别:面上项目
- 资助金额:27.0万元
- 批准年份:2005
- 负责人:沈玉先
- 依托单位:
国内基金
海外基金















{{item.name}}会员


